Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data

Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data

Background Recent publications reached conflicting conclusions about the cost‐effectiveness of left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, Marlborough, MA) for stroke risk reduction in nonvalvular atrial fibrillation (AF). This analysis sought to assess the cost...

Full description

Bibliographic Details
Main Authors: Vivek Y. Reddy, Ronald L. Akehurst, Meghan B. Gavaghan, Stacey L. Amorosi, David R. Holmes
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulant
atrial fibrillation
cost‐effectiveness
left atrial appendage closure
nonwarfarin oral anticoagulants
Watchman
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.011577

Similar Items

Similar Items